SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-041373
Filing Date
2022-07-06
Accepted
2022-07-06 18:53:11
Documents
1
Period of Report
2022-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7621
  Complete submission text file 0001209191-22-041373.txt   9000
Mailing Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102 (206) 737-0085
Icosavax, Inc. (Issuer) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ICOSAVAX, INC. 1616 EASTLAKE AVENUE E., SUITE 208 SEATTLE WA 98102
Business Address
Simpson Adam K. (Reporting) CIK: 0001873839 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40655 | Film No.: 221070171